Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines

Arun I, 2007, Biomaterials, 10, 1871

10.1158/1078-0432.CCR-05-1673

Courtice FC, 1963, Lymph and lymphatic system, 89

10.1152/japplphysiol.00106.2004

10.1038/sj.bjc.6600270

10.1093/jnci/90.12.889

10.1016/S1461-5347(99)00211-4

Fang J, 2002, Cancer Res, 62, 3138

Fingar VH, 1996, J Clin Laser Med Surg, 14, 323, 10.1089/clm.1996.14.323

10.1056/NEJM197108122850711

10.1038/nm0195-27

10.1081/CNV-100103136

10.2165/00003495-199700544-00005

10.2165/00003088-200342130-00002

10.1016/j.jconrel.2004.03.027

10.1021/bc040297g

Guyton AC, 2000, Textbook of medical physiology10th ed., 358

10.1016/S0002-9440(10)65006-7

10.1111/j.1349-7006.1991.tb01797.x

10.1111/j.1349-7006.1999.tb00851.x

10.1111/j.1349-7006.2000.tb00940.x

Jain R, 1988, Cancer Res, 10, 2641

10.1038/scientificamerican0794-58

10.1177/088391158800300401

10.1016/S0959-8049(05)80063-2

10.1002/1097-0142(19841201)54:11<2367::AID-CNCR2820541111>3.0.CO;2-F

10.1016/S0168-3659(01)00330-3

10.1006/jsre.2001.6299

Leaf C, 2004, Fortune, 149, 84

Leu A, 2000, Cancer Res, 60, 4324

10.1038/bjc.1993.179

10.1016/0169-409X(91)90040-J

10.1016/S0065-2571(00)00013-3

Maeda H, 1989, Crit Rev Ther Drug Carrier Syst, 6, 193

Maeda H, 1979, Int J Pept Protein Res, 2, 81, 10.1111/j.1399-3011.1979.tb01730.x

Maeda H, 1984, Gan To Kagaku Ryoho, 4, 814

Maeda H, 1986, Protein tailoring for food and medical uses, 353

10.1177/088391158800300104

Maeda H, 1988, J Biol Chem, 31, 16051, 10.1016/S0021-9258(18)37555-0

10.1111/j.1349-7006.1994.tb02362.x

10.1016/0162-3109(96)00063-X

10.1016/S0162-3109(99)00104-6

10.1016/S0168-3659(01)00309-1

10.1016/S1567-5769(02)00271-0

10.1113/jphysiol.1914.sp001668

Matsumura Y, 1986, Cancer Res, 46, 6387

10.1111/j.1349-7006.1988.tb01563.x

10.1111/j.1349-7006.1991.tb01910.x

10.1023/A:1007500412442

10.2745/dds.18.438

10.1289/ehp.98106s51205

10.1111/j.1349-7006.1998.tb00563.x

Noguchi R, 2003, Clin Cancer Res, 9, 6038

Oda T, 1987, Cancer Res, 47, 3206

10.1074/jbc.M102417200

10.1016/0167-4889(95)91997-Z

10.1016/0142-9612(89)90075-6

10.1126/science.6823562

Skinner S, 1990, Cancer Res, 50, 2411

10.1038/nm1247

Suzuki M, 1981, J Natl Cancer Inst, 67, 663

10.1002/1097-0142(19870201)59:3<444::AID-CNCR2820590316>3.0.CO;2-5

10.1080/1061186031000086072

10.2174/1568009054629663

Weir EK, 1995, FASEB J, 9, 183, 10.1096/fasebj.9.2.7781921

Wu J, 1998, Cancer Res, 58, 159

10.1111/j.1349-7006.2001.tb01114.x

10.1016/S0306-3623(99)00019-1

10.1038/sj.cgt.7700122

Yuan F, 1995, Cancer Res, 55, 3752

10.1002/1097-0142(1955)8:1<123::AID-CNCR2820080116>3.0.CO;2-A